Petitioner: DEPARTMENT OF BUSINESS AND PROFESSIONAL REGULATION, DIVISION OF DRUGS, DEVICES AND COSMETICS
Respondent: RED PARROT DISTRIBUTION, INC.
Judges: J. LAWRENCE JOHNSTON
Agency: Department of Business and Professional Regulation
Locations: Clearwater, Florida
Filed: Dec. 27, 2013
Status: Closed
Settled and/or Dismissed prior to entry of RO/FO on Tuesday, April 29, 2014.
Latest Update: Apr. 08, 2025
. Deputy Agenoy Clark
STATE OF FLORIDA CLERK vette Laweon-Proctor
DEPARTMENT OF BUSINESS & PROFESSIONAL REGULAT| ome 7744/2013
Fie?
DEPARTMENT OF BUSINESS &
PROFESSIONAL REGULATION,
Petitioner,
¥v. CASE NO.: 2013-024069
RED PARROT DISTRIBUTION, INC.,
Respondent.
/
ADMINISTRATIVE COMPLAINT
COMES NOW, Petitioner, Department of Business & Professional Regulation
(‘Department’), and files this Administrative Complaint against Respondent, Red Parrot
Distribution, Inc., (“Respondent” or “Red Parrot"), and in support thereof alleges:
1. Petitioner is the state department charged with regulating Drugs, Devices
and Cosmetics pursuant to Section 20.165 and Chapter 499, Florida Statutes. .
2. Respondent is permitted by the Department as a prescription drug
wholesale distributor, having received Permit number 22:20190 on or about May 19,
2011.
3. Respondent's permitted addrass of record is 202 10" Avenue North, Suite
A, Safety Harbor, Florida 34695.
4. On or about June 12 and 13, 2013, Department inspectors conducted a
routine compliance inspection at the Respondent’s permitted address.
5. Inspectors observed Red Parrot’s operations, interviewed key personnel,
and reviewed Red Parrot’s business records.
6. During the inspection, Inspectors spoke with Mr. Joseph P. Spinosa,
President, Mrs. Heather Spinosa, Certified Designated Representative, Vice President
and registered Agent of the company.
7. Inspectors also spoke with Red Parrot’s warehouse manager, and with
warehouse staff.
8. Red Parrot employees advised Department inspectors that with each
distribution of prescription drugs, the customer receives an invoice.
9. Red Parrot employees also advised the Department that inbound
pedigrees are authenticated by the following process:
a. Employee verifies that the prescription drug that is received
is the drug the company ordered.
b. An employee looks at the vendor's inbound invoice /packing
slip and compares it to the firm’s purchase order.
c. An employee verifies the drug’s NDC number, lot number,
strength, and expiration date.
d. Once the employee verifies that what was ordered is what
was received, the employee puts on the pedigree the date the information
was verified, the Red Parrot purchase order number, and the initials of the
person verifying the information.
e. Once verified, the prescription drugs are placed into
inventory in a designated bin.
10. Red Parrot does not authenticate each transaction on the pedigree papers
it receives in the manner required by Section 499.0121(4)(d), Florida Statutes, and Rule
61N-1.013(5)(d), Fiorida Administrative Code.
11. Red Parrot does not provide a prescription drug pedigree to customers to
whom Red Parrot distributes prescription drugs, unless the customer requests the
pedigree.
12. Specifically, Respondent distributed the following prescription drugs in
May and June 2013:
a. From on or about May 16, 2013, to on or about June 15,
2013, Red Parrot distributed 57 prescription drugs to Trinity Pharmacy,
11130 Seminole Blvd., Seminole, Florida 33778 (‘Trinity’), using invoice
numbers 29637, 29758, 29760, 29904, 30112, 30173, and 30181.
b. From on or about May 8, 2013, to on or about June 7, 2013,
Red Parrot distributed 142 prescription drugs to The RX Shop, Rang, Inc.,
810 South F Harrison Avenue, Clearwater, Florida 33756 (“RX Shop’),
using invoice numbers 29590, 59618, 29715, 29753, 29747, 29751,
29783, 29784, 29638, 29822, 29854, 29906, 29969, 29994, 30012,
30035, 30066, 30064, 30096, 30118, 30164, 30160, 30164, and 30178.
Cc. From on or about May 13, 2013, to on or about June 6,
2013, Red Parrot distributed 40 prescription drugs to ASAP Pharmacy,
8609 66" Street North, Suite C, Pinellas Park, Florida 33782 (“ASAP”),
using invoice numbers 29711, 29712, 29818, 29819, 29869, 29870,
30092, 30094, 30153, and 30156.
d. From on or about May 8, 2013 to on or about June 7, 2013,
Red Parrot distributed 207 prescription drugs to Superior Pharmacy, LLC,
Superior Pharmacy Vital Care, 5416 Town N Country Bivd., Tampa,
Florida 33615, (Superior), using invoice numbers 29605, 29609, 29614,
29615, 29625, 29684, 29720, 29721, 29722, 29727, 29774, 29781,
29796, 29797, 29802, 29856, 29865, 29888, 29892, 29895, 29902,
29934, 29943, 29977, 30019, 30048, 30049, 30076, 30099, 30111,
30142, 30155, 30159, 30161, 30170, and 30174.
e. From on or about May 20, 2013 to on or about June 1, 2013,
Red Parrot distributed 11 prescription drugs to Advanced Medical
Pharmacy, Inc., 3614 West Kennedy Bivd., Suite C, Tampa, Florida
33609 (“Advance"), using invoice numbers 29717, 29718, 29771, 29954,
and 30085.
13. Red Parrot did not provide a prescription drug pedigree prior to or
simultaneously with the distribution of the 457 separate prescription drugs referenced in
paragraph 12 a.-e.
14. Section 499.01212, Florida Statutes provides:
499.01212 Pedigree paper.—
(1) APPLICATION.—Each person who is engaged in the wholesale
distribution of a prescription drug must, prior to or simultaneous with each
wholesale distribution, provide a pedigree paper to the person who
receives the drug.
(2) FORMAT.—A pedigree paper must contain the following
information:
(a) For the wholesale distribution of a prescription drug within the
normal distribution chain:
1. The following statement: “This wholesale distributor purchased the
specific unit of the prescription drug directly from the manufacturer.”
2. The manufacturers national drug code identifier and the name and
address of the wholesale distributor and the purchaser of the prescription
drug.
3. The name of the prescription drug as it appears on the label.
4. The quantity, dosage form, and strength of the prescription drug.
The wholesale distributor must also maintain and make available to the
department, upon request, the point of origin of the prescription drugs,
including intracompany transfers, the date of the shipment from the
manufacturer to the wholesale distributor, the Jot numbers of such drugs,
and the invoice numbers from the manufacturer.
(b) For all other wholesale distributions of prescription drugs:
1. The quantity, dosage form, and strength of the prescription drugs.
2. The lot numbers of the prescription drugs.
3. The name and address of each owner of the prescription drug and
his or her signature.
4. Shipping information, including the name and address of each
person certifying delivery or receipt of the prescription drug.
5. An invoice number, a shipping document number, or another
number uniquely identifying the transaction.
6. A certification that the recipient wholesale distributor has
authenticated the pedigree papers.
7. The unique serialization of the prescription drug, if the manufacturer
or repackager has uniquely serialized the individual prescription drug unit.
8. The name, address, telephone number, and, if available, e-mail
contact information of each wholesale distributor involved in the chain of
the prescription drug’s custody.
15. Section 499.0121(4)(d), Florida Statutes, provides:
499.0121 Storage and handling of prescription drugs;
recordkeeping.—
(4) EXAMINATION OF MATERIALS AND RECORDS.—
(a) Upon receipt, each outside shipping container must be visually
examined for identity and to prevent the acceptance of contaminated
prescription drugs that are otherwise unfit for distribution. This
examination must be adequate to reveal container damage that would
suggest possible contamination or other damage to the contents.
(b) Each outgoing shipment must be carefully inspected for identity of
the prescription drug products and to ensure that there is no delivery of
prescription drugs that have expired or been damaged in storage or held
under improper conditions.
(c) The recordkeeping requirements in subsection (6) must be followed
for all incoming and outgoing prescription drugs.
(d) Upon receipt, a wholesale distributor must review records required
under this section for the acquisition of prescription drugs for accuracy and
completeness, considering the total facts and circumstances surrounding
the transactions and the wholesale distributors involved. This includes
authenticating each transaction listed on a pedigree paper, as defined in s.
499.003(37). [Emphasis supplied].
16. Prescription drug transactions listed in a pedigree must be authenticated
using one of the methods set forth in Rule 61N-1.013(5)(d), Florida Administrative
Code.
17. Section 499.006(10), Florida Statutes (2012), provides:
499.006 Adulterated drug or device.--A drug or device is adulterated:
* * *
(10) If it is a prescription drug for which the required pedigree paper is
nonexistent, fraudulent, or incomplete under the requirements of this part
or applicable rules, or that has been purchased, held, sold, or distributed
at any time by a person not authorized under federal or state law to do so;
or
18. Red Parrot adulterated each of the 457 prescription drugs referenced in
paragraphs 12 a.-e. above, that it delivered without a prescription drug pedigree, as
required by Sections 499.01212, and 499.005(28), Florida Statutes (2012).
19. Red Parrot failed to authenticate the pedigrees it received during the
months of May and June, 2013, in the manner required in Section 499.0121(4)(d),
Florida Statutes (2012), and Rule 61N-1.013(5)(d), Florida Administrative Code.
COUNT ONE
20. Petitioner re-alleges and incorporates paragraphs 1-19 as if fully set forth
herein this count one.
21. Section 499.005(28), Florida Statutes (2012), provides that the failure to
acquire or deliver a prescription drug pedigree as required under Part !, Chapter 499, is
unlawful.
22. Red Parrot failed to deliver prescription drug pedigrees either prior to, or
simultaneously with, the 57 prescription drugs that it distributed to Trinity during the
months of May and June, 2013.
23. Based on the foregoing, Red Parrot violated Section 499.005(28), Florida
statutes (2012), by failing to deliver a prescription drug pedigree prior to or
simultaneously with each of the 57 prescription drugs it distributed to Trinity.
COUNT TWO
24. Petitioner re-alleges and incorporates paragraphs 1-19 as if fully set forth
herein this count two.
25. Section 499.005(28), Florida Statutes (2012), provides that the failure to
acquire or deliver a prescription drug pedigree as required under Part |, Chapter 499, is
unlawful.
26. Red Parrot failed to deliver prescription drug pedigrees either prior to, or
simultaneously with, the 142 prescription drugs that it distributed to RX Shop during the
months of May and June, 2013.
27. Based on the foregoing, Red Parrot violated Section 499.005(28), Florida
Statutes (2012), by failing to deliver a prescription drug pedigree prior to or
simultaneously with each of the 57 prescription drugs it distributed to RX Shop, during
the months of May and June, 2013.
COUNT THREE
28. Petitioner re-alleges and incorporates paragraphs 1-19 as if fully set forth
herein this count three.
29. Section 499.005(28), Florida Statutes (2012), provides that the failure to
acquire or deliver a prescription drug pedigree as required under Part |, Chapter 499, is
unlawful.
30. Red Parrot failed to deliver prescription drug pedigrees either prior to, or
simultaneously with, the 40 prescription drugs that it distributed to ASAP during the
months of May and June, 2013.
31. Based on the foregoing, Red Parrot violated Section 499.005(28), Florida
Statutes (2012), by failing to deliver a prescription drug pedigree prior to or
simultaneously with each of the 40 prescription drugs it distributed to ASAP, during the
months of May and June, 2013
COUNT FOUR
32. Petitioner re-alleges and incorporates paragraphs 1-19 as if fully set forth
herein this count four.
33. Section 499.005(28), Florida Statutes (2012), provides that the failure to
acquire or deliver a prescription drug pedigree as required under Part |, Chapter 499, is
untawful.
34. Red Parrot failed to deliver prescription drug pedigrees either prior to, or
simultaneously with, the 207 prescription drugs that it distributed to Superior during the
months of May and June, 2013.
35. Based on the foregoing, Red Parrot violated Section 499.005(28), Florida
Statutes (2012), by failing to deliver a prescription drug pedigree prior to or
simultaneously with each of the 207 prescription drugs it distributed to Superior, during
the months of May and June, 2013
COUNT FIVE
36. Petitioner re-alleges and incorporates paragraphs 1-19 as if fully set forth
herein in this count five.
37. Section 499.005(28), Florida Statutes (2012), provides that the failure to
acquire or deliver a prescription drug pedigree as required under Part !, Chapter 499, is
unlawful.
38. Red Parrot failed to deliver prescription drug pedigrees either prior to, or
simultaneously with, the 11 prescription drugs that it distributed to Advanced during the
months of May and June, 2013.
39. Based on the foregoing, Red Parrot violated Section 499.005(28), Florida
Statutes (2012), by failing to deliver a prescription drug pedigree prior to or
simultaneously with each of the 11 prescription drugs it distributed to Advanced, during
the months of May and June, 2013
COUNT Six
40. Petitioner re-alleges and incorporates paragraphs 1-19 as if fully set forth
herein this count six.
41. Section 499.005(2), Florida Statutes (2012), provides that the adulteration
or misbranding of any drug, device or cosmetic is unlawful.
42. Red Parrot adulterated, within the meaning of Section 499.006(10) Florida
Statutes (2012), each of the 57 prescription drugs that it distributed to Trinity without a
prescription drug pedigree, as required by Section 499.01212, Florida Statutes.
43. Based upon the foregoing, Red Parrot violated Section 499.005(2), Florida
Statutes (2012), by adulterating each of the 57 prescription drugs it distributed to Trinity
without a prescription drug pedigree.
COUNT SEVEN
44. Petitioner re-alleges and incorporates paragraphs 1-19 as if fully set forth
herein this count seven.
45. Section 499.005(2), Florida Statutes (2012), provides that the adulteration
or misbranding of any drug, device or cosmetic is unlawful.
46. Red Parrot adulterated, within the meaning of Section 499.006(10) Florida
Statutes (2012), each of the 142 prescription drugs that it distributed to RX Shop without
a prescription drug pedigree, as required by Section 499.01212, Florida Statutes.
47. Based upon the foregoing, Red Parrot violated Section 499.005(2), Florida
Statutes (2012), by adulterating each of the 142 prescription drugs it distributed to RX
Shop without a prescription drug pedigree.
COUNT EIGHT
48. Petitioner re-alleges and incorporates paragraphs 1-19 as if fully set forth
herein this count eight.
49. Section 499.005(2), Florida Statutes (2012), provides that the adulteration
or misbranding of any drug, device or cosmetic is unlawful.
50. Red Parrot adulterated, within the meaning of Section 499.006(10) Florida
Statutes (2012), each of the 40 prescription drugs that it distributed to ASAP without a
prescription drug pedigree, as required by Section 499.01212, Florida Statutes.
10
51. Based upon the foregoing, Red Parrot violated Section 499.005(2), Florida
Statutes (2012), by adulterating each of the 40 prescription drugs it distributed to ASAP
without a prescription drug pedigree.
COUNT NINE
52. Petitioner re-alleges and incorporates paragraphs 1-19 as if fully set forth
herein this count nine.
53. Section 499.005(2), Florida Statutes (2012), provides that the adulteration
or misbranding of any drug, device or cosmetic is unlawful.
54. Red Parrot adulterated, within the meaning of Section 499.006(10) Florida
Statutes (2012), each of the 207 prescription drugs that it distributed to Superior without
a prescription drug pedigree, as required by Section 499.01212, Florida Statutes.
55. Based upon the foregoing, Red Parrot violated Section 499.005(2), Florida
Statutes (2012), by adulterating each of the 207 prescription drugs it distributed to
Superior without a prescription drug pedigree.
COUNT TEN
56. Petitioner re-alleges and incorporates paragraphs 1-19 as if fully set forth
herein this count ten.
57. Section 499.005(2), Florida Statutes (2012), provides that the adulteration
or misbranding of any drug, device or cosmetic is unlawful.
58. Red Parrot adulterated, within the meaning of Section 499.006(10) Florida
Statutes (2012), each of the 11 prescription drugs that it distributed to Advanced without
a prescription drug pedigree, as required by Section 499.01212, Florida Statutes.
11
59. Based upon the foregoing, Red Parrot violated Section 499.005(2), Florida
Statutes (2012), by adulterating each of the 11 prescription drugs it distributed to
Advanced without a prescription drug pedigree.
COUNT ELEVEN
60. Petitioner re-alleges and incorporates paragraphs 1-19 as if fully set forth
herein this count eleven.
61. Section 499.005(28), Florida Statutes (2012), provides that the failure to
acquire or deliver a pedigree, is unlawful.
62. Red Parrot advised the Department that it failed to acquire a prescription
drug pedigree for each prescription drug that it received.
63. Based on the foregoing, Red Parrot violated Section 499.005(28), Florida
Statutes (2012), by failing to acquire a prescription drug pedigree for each prescription
drug that it received.
COUNT TWELVE
64. Petitioner re-alleges and incorporates paragraphs 1-19 as if fully set forth
herein in this count twelve.
65. Section 499.005(4), Florida Statutes (2012), provides that the sale,
distribution, purchase, trade, holding or offering of any drug, device or cosmetic in
violation of this part, is unlawful.
66. Section 499.0121(4)(d), Florida Statutes (2012), requires prescription drug
distributors to authenticate each transaction on a pedigree paper. Rule 61N-013(5)(d),
sets forth the methods by which a prescription drug pedigree transaction must be
authenticated and authorizes a prescription drug wholesale distributor to choose any,
12
all, or a combination of the methods for authentication enumerated in the rule. At a
minimum, a prescription drug wholesale distrioutor must contact the seller as part of the
verification process.
67. Red Parrot’s method of authenticating pedigrees by merely checking to
see whether the drugs received were the drugs that were ordered, and initialing the
invoice, fails to comply with the statutory and rule requirements for authentication.
68. Based on the foregoing, Red Parrot violated Section 499.005(4), Florida
Statutes (2012), by holding and offering prescription drugs for sale when Red Parrot
had failed to authenticate each transaction on the pedigrees it received from sellers, as
required by Section 499.0121(4)(d), and Rule 61N-1.013 (5)(d), Florida Administrative
Code.
PRAYER FOR RELIEF
WHEREFORE, Petitioner respectfully requests an order imposing the following
penalties: the imposition of administrative fines in accordance with the disciplinary
guidelines, suspension, revocation, and such other and further relief as is provided by
Dated this (ey of sjehy , 2013.
law.
BY:
DBPR - Drugs, Devices and Sosmetics Division
1940 North Monroe Street, Suite 26A
Tallahassee, FL 32399-1047
Telephone: (850) 717-1800
Facsimile: (850) 414-8240
13
Prepared by:
Kathryn E. Pri
Chief Attorne’
Department of Business & Professional Regulation
Division of Drugs, Devices and Cosmetics
1940 North Monroe Street, Suite 26A
Tallahassee, Florida 32399-1047
NOTICE OF RIGHTS
Respondent has the right to request a hearing to be conducted in accordance
with Sections 120.569 and 120.57, Florida Statutes, to be represented by counsel or
other qualified representative, to present evidence and argument, to call and cross-
examine witnesses and to have subpoena and subpoena duces tecum issued on his or
her behalf if a hearing is requested.
14
Docket for Case No: 13-004973
Issue Date |
Proceedings |
Apr. 29, 2014 |
Order Closing File and Relinquishing Jurisdiction. CASE CLOSED.
|
Apr. 29, 2014 |
Joint Motion to Relinquish Jurisdiction filed.
|
Apr. 25, 2014 |
Notice of Cancellation of Deposition Duces Tecum (of Mary Mayleben and Nancy McGowan) filed.
|
Apr. 25, 2014 |
Notice of Cancelling Depositions Duces Tecum filed.
|
Apr. 24, 2014 |
Respondent Red Parrot Distribution, Inc. Request for Issuances of Subpoenas filed.
|
Apr. 23, 2014 |
Notice of Taking Deposition Duces Tecum (of Mary Mayleben and Nancy McGowan) filed.
|
Apr. 22, 2014 |
Notice of Taking Depositions Duces Tecum (of Joseph Spinosa, Michael Brennan, Raysa Gonzalez, and Heather Spinosa) filed.
|
Apr. 11, 2014 |
Notice of Retaining Court Reporter filed.
|
Apr. 09, 2014 |
Notice of Appearance of Co-Counsel (Beth Miller) filed.
|
Mar. 17, 2014 |
Amended Notice of Hearing (hearing set for May 7 and 8, 2014; 9:00 a.m.; Clearwater, FL; amended as to location of hearing).
|
Feb. 11, 2014 |
Notice of Serving Respondent's Responses to Petitioner's First Set of Interrogatories filed.
|
Feb. 11, 2014 |
Respondent's Response to Petitioner's First Request for Admissions filed.
|
Feb. 11, 2014 |
Respondent's Response to Petitioner's First Request for Production filed.
|
Feb. 10, 2014 |
Order Granting Continuance and Re-scheduling Hearing (hearing set for May 7 and 8, 2014; 9:00 a.m.; Clearwater, FL).
|
Feb. 10, 2014 |
(Respondent's) Unopposed Motion to Continue Formal Hearing filed.
|
Jan. 27, 2014 |
Order on Motion to Clarify.
|
Jan. 16, 2014 |
Motion for Clarification of Respondent's Notice of Unavailability in Light of Prehearing Order filed.
|
Jan. 13, 2014 |
Notice of Unavailability filed.
|
Jan. 09, 2014 |
Amended Notice of Hearing (hearing set for March 6 and 7, 2014; 9:00 a.m.; Clearwater, FL; amended as to location of hearing).
|
Jan. 07, 2014 |
Notice of Service of Petitioner's First Request for Production, First Request for Interrogatories and First Request for Admissions to Respondent filed.
|
Jan. 06, 2014 |
Order of Pre-hearing Instructions.
|
Jan. 06, 2014 |
Notice of Hearing (hearing set for March 6 and 7, 2014; 9:00 a.m.; Clearwater, FL).
|
Jan. 03, 2014 |
Joint Response to Initial Order filed.
|
Dec. 27, 2013 |
Initial Order.
|
Dec. 27, 2013 |
Administrative Complaint filed.
|
Dec. 27, 2013 |
Notice of Appearance (Kathryn E. Price).
|
Dec. 27, 2013 |
Agency referral filed.
|
Dec. 27, 2013 |
Election of Rights filed.
|